期刊文献+

持续皮下注射胰岛素治疗糖尿病合并甲亢患者的临床疗效 被引量:6

下载PDF
导出
摘要 目的探讨持续皮下注射胰岛素治疗糖尿病合并甲亢患者的临床疗效。方法选取2014年1月至2015年4月住院接受治疗的83例糖尿病合并甲亢患者,采用随机抽签法将其分为对照组和试验组。对照组给予常规皮下多次注射胰岛素;试验组给予持续皮下注射胰岛素。结果试验组2周血糖达标率高于对照组(P<0.05);试验组低血糖率、餐后高血糖率、甲亢高代谢率低于对照组(P<0.05);试验组相比于对照组血糖控制时间更短、胰岛素总用量更少、空腹血糖、餐后2 h血糖均更低(P<0.05)。结论持续皮下注射胰岛素治疗糖尿病合并甲亢的临床疗效确切,可有效改善患者血糖水平,快速控制血糖,减少胰岛素用量,减少低血糖率、餐后高血糖率、甲亢高代谢率,提高2周血糖达标率,对患者预后有益,值得推广。
作者 裴薇
出处 《医疗装备》 2016年第15期86-87,共2页 Medical Equipment
  • 相关文献

参考文献6

二级参考文献31

  • 1马静,杨玲凤.胰岛素泵在2型糖尿病合并甲亢患者中的应用效果及护理[J].当代护士(下旬刊),2009,16(4):15-16. 被引量:6
  • 2潘长玉,中国区合作调查组.中国糖尿病控制现状——指南与实践的差距 亚洲糖尿病治疗现状调查1998,2001及2003年中国区结果介绍[J].国外医学(内分泌学分册),2005,25(3):174-178. 被引量:395
  • 3Meneghini LF, Rosenberg KH, Koenen C,et al. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine; clinical practice experience from a German subgroup of the PREDICTIVE study [J]. Diabetes Obes Metah, 2007,9(3):418-427.
  • 4Hermansen K, Dornhorst A, Sreenan S. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal bolus regimens: insights from the PREDICTIVE study. Curr Med Res Opin [J]. 2009,25(11):2601-2608.
  • 5Thomsen TL, Heintjes EM, Penning-van Beest FJA, et al. Real-life prescription patterns show fewer treatment changes with basal insulin analogs compared to NPH in type 2 diabetes in the Netherlands [poster]. ISPOR 12^TH ANNUAL EUROPEAN CONGRESS, Paris, France, 2009.
  • 6Borah B J, Darkow T, Bouchard J, et al. A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes [J]. Clin Ther, 2009,31(3)..623-631.
  • 7Pahner A J, Valentine W J, Ray JA, et al. An economic assessment of analogue basal bolus insulin versus human basal bolus insulin in subjects with type 1 diabetes in the UK [J]. Curr Med Res Opin. 2007,23(4): 895-901.
  • 8Tunis SL, Minshall ME, Conner C, et al. Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis[J]. Curr Med Res Opin. 2009,25(5): 1273-1284.
  • 9Gschwend MH, Aagren M, Valentine WJ, et al.Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries [J]. J Med Econ, 2009,12(2):114-123.
  • 10Valentine WJ, Goodall G, Aagren M, et al. Evaluating the Cost-Effectiveness of Therapy Conversion to Insulin Detemir in Patients with Type 2 Diabetes in Germany: a Modelling Study of Long-Term Clinical and Cost Outcomes [J]. Adv Ther, 2008,25(6) : 567-584.

共引文献37

同被引文献32

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部